entertainment -WSS

entertainment

author：Wikipedia 2025-08-26 02:49:19 - browse：2313

Medical illustration of Streptococcus pneumoniae bacteria — A medical illustration of drug-resistant, Streptococcus pneumoniae bacteria. Antibiotic Resistance Coordination and Strategy Unit/CDC

Micronoma, a San Diego-based biotech startup, was founded on the idea that signatures from microbes that colonize tumors could lead to a blood test to detect cancer. The hypothesis was based on a high-profile Nature paper, published in 2020, that suggested these microbes are consistently found in tumors, and that they create such specific signatures they could be used to identify cancer types with nearly 100% accuracy.

But late Monday night, a team of researchers published a manuscript on the preprint site bioRxiv.com showing what they believe to be two “fatal errors” in the Nature paper’s analyses, invalidating not only the paper’s findings but possibly the scientific foundation for Micronoma, which has raised an estimated $17.5 million in funding from investors including SymBiosis Capital Management and the Seerave Foundation.

One allegation is that the Nature paper’s authors didn’t adequately filter out human DNA from their database of tumor samples, leading them to incorrectly classify millions of human sequences as bacterial. The other is that a separate error led the team’s algorithm to find false associations between specific microbial signatures and cancer types.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Heart disease and mental health: A look at cardiac psychology

WSS

Health and fitness trackers are measuring the wrong things

Why health care costs have stayed mostly flat since 2010

JPM 2024: Verve Therapeutics looks to mainstream genome editing

The SUPPORT Act is critical to fighting the opioid crisis

New menopause drug shows promise in relief for hot flashes

Heart disease and mental health: A look at cardiac psychology

focus

entertainment

focus

Alkermes shareholders re

JPM 2024: Verve Therapeutics looks to mainstream genome editing

United colonoscopy coverage change 'may cost lives,' doctors say

Virtual care provider acquires bankrupt Pear's prescription apps

Hollywood unions extend contract negotiations for actors

SEC charges former device maker CEO with $41 million fraud

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

As demand for Covid shots wanes, Moderna seeks its next success

Health and fitness trackers are measuring the wrong things

Wikipedia

Hospitals owned by private equity see complications spike 25%

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Doulas covered by Medicaid under New York's new plan

How to keep neuroscience’s past racism from being its future

Virtual care provider acquires bankrupt Pear's prescription apps

Generative AI mines health records to identify patients’ social needs

focus

explore

hotspot

entertainment